MSN: Jason Collins, premier joueur de NBA à avoir révélé son homosexualité, est en phase terminale d'un cancer
Jason Collins, premier joueur de NBA à avoir révélé son homosexualité, est en phase terminale d'un cancer
Business Wire: Imvax Announces First Patient Dosed in Phase 2b Trial of IGV-001 for Glioblastoma
Imvax Announces First Patient Dosed in Phase 2b Trial of IGV-001 for Glioblastoma
Seeking Alpha: IN8bio Completes Dose Escalation in Phase 1 Trial of INB-100, a Potential First-in-Class Gamma-Delta T Cell Therapy for the Treatment of Leukemias, and Initiates Enrollment for ...
Enrollment is now open in the company-sponsored Phase 2 clinical trial of INB-400 in patients with newly diagnosed glioblastoma multiforme (GBM). Enrollment completed in the dose escalation phase of ...
IN8bio Completes Dose Escalation in Phase 1 Trial of INB-100, a Potential First-in-Class Gamma-Delta T Cell Therapy for the Treatment of Leukemias, and Initiates Enrollment for ...
Morningstar: Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
manilatimes: Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
Business Wire: Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
Seeking Alpha: Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) for the Treatment of Glioblastoma at the ASCO 2025 Annual Meeting
Favorable safety profile and encouraging early efficacy signals support advancement to Phase II trial of dendritic cell vaccine for the treatment of glioblastoma. HOUSTON, /PRNewswire/ -- ...